Donate
Donate to AGSD

Thank you for your support!

Become a Member
Become a Member

Access to scholarships, events, and more!

Published On: October 19, 2026

Press Release

Beam Therapeutics to Present Initial Data from Phase 1/2 Trial of BEAM-301 in Glycogen Storage Disease Type Ia (GSDIa) at the ESGCT 33rd Annual Congress